Spatial transcriptomic analysis of delayed-type hypersensitivity skin biopsies has identified critical immune pathways regulating cell-mediated immunity against Leishmania parasites in humans. Researchers evaluated skin biopsies collected after intradermal leishmanin antigen inoculation in individuals living in endemic foci, uncovering distinct molecular mediators of the local immune response compared with healthy tissue.
A delayed-type hypersensitivity response elicited by intradermal leishmanin antigen inoculation serves as a reliable indicator of cell-mediated immunity in exposed populations. The leishmanin skin test remains an important tool for disease surveillance in endemic regions and for assessing vaccine efficacy, yet previous investigations into cellular immunity were limited to peripheral blood mononuclear cells.
Spatial profiling demonstrated that macrophages and T cells, which associate with a positive hypersensitivity reaction, were significantly elevated in the post-inoculation biopsies compared to healthy skin. Furthermore, cytokines interleukin-16 and tumor necrosis factor, known to attract CD4-positive T cells, were elevated in Langerhans cells within the delayed-type hypersensitivity tissue, alongside elevated levels of both interferon-gamma receptors.
The investigation also revealed elevated levels of chemokines CCL2, CCL5, CCL8, and CCL19, together with their corresponding cellular receptors, in the reactive tissue samples. Analysis utilizing the CellChat tool highlighted the interaction between chemokine CCL19 and receptor CCR7 as the most salient signaling dynamic driving cell recruitment within the reactive skin sites.
These findings define key molecular biomarkers characterizing the delayed-type hypersensitivity response following leishmanin exposure in humans. By detailing these localized mediators, the research provides molecular evidence to guide the appropriate formulation and reintroduction of standardized leishmanin skin test antigens for clinical evaluation and field-based disease surveillance.
Subject of Research: Cell-mediated immune pathways in human leishmaniasis skin tests
Article Title: Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans
Article References: Abdelrahim, S. M., Gasim, K. E. A., Musa, Y. B., Karaiskos, S., Santana-Quintero, L., Nakhasi, H. L., Mudawi, M. A., Gannavaram, S., & Satoskar, A. R. (2026). Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans. PLOS Neglected Tropical Diseases, 20(11), e0014743. https://doi.org/10.1371/journal.pntd.0014743
Image Credits: AI Generated
DOI: 10.1371/journal.pntd.0014743
Keywords: Leishmania, leishmaniasis, delayed-type hypersensitivity, cell-mediated immunity, leishmanin skin test, spatial transcriptomics, skin biopsy, macrophages, T cells, Langerhans cells, interleukin-16, tumor necrosis factor, interferon-gamma receptors, CCL19, CCR7, chemokines, disease surveillance
Cite Scienmag News
Brooke Gardner. (November 20, 2026). Spatial Transcriptomics Identifies Key Immune Pathways in Human Leishmanin Skin Tests. Scienmag. https://scienmag.com/spatial-transcriptomics-identifies-key-immune-pathways-in-human-leishmanin-skin-tests/
Brooke Gardner. "Spatial Transcriptomics Identifies Key Immune Pathways in Human Leishmanin Skin Tests." Scienmag, 20 November 2026, https://scienmag.com/spatial-transcriptomics-identifies-key-immune-pathways-in-human-leishmanin-skin-tests/. Accessed 20 November 2026.
Brooke Gardner. "Spatial Transcriptomics Identifies Key Immune Pathways in Human Leishmanin Skin Tests." Scienmag. November 20, 2026. https://scienmag.com/spatial-transcriptomics-identifies-key-immune-pathways-in-human-leishmanin-skin-tests/








